Cancer Research Meeting Calendar Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luo, J.
Right arrow Articles by Isaacs, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luo, J.
Right arrow Articles by Isaacs, W. B.
[Cancer Research 61, 4683-4688, June 15, 2001]
© 2001 American Association for Cancer Research

Advances in Brief

Human Prostate Cancer and Benign Prostatic Hyperplasia

Molecular Dissection by Gene Expression Profiling1

Jun Luo2, David J. Duggan2, Yidong Chen, Jurga Sauvageot, Charles M. Ewing, Michael L. Bittner, Jeffrey M. Trent and William B. Isaacs3

Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-2101 [J. L., J. S., C. M. E., W. B. I.], and Cancer Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland 20892-4470 [D. J. D., Y. C., M. L. B., J. M. T.]

Critical aspects of the biology and molecular basis for prostate malignancy remain poorly understood. To reveal fundamental differences between benign and malignant growth of prostate cells, we performed gene expression profiling of primary human prostate cancer and benign prostatic hyperplasia (BPH) using cDNA microarrays consisting of 6500 human genes. Frozen prostate specimens were processed to facilitate extraction of RNA from regions of tissue enriched in either benign or malignant epithelial cell growth within a given specimen. Gene expression in each of the 16 prostate cancer and nine BPH specimens was compared with a common reference to generate normalized measures for each gene across all of the samples. Using an analysis of complete pairwise comparisons of expression profiles among all of the samples, we observed clearly discernable patterns of overall gene expression that differentiated prostate cancer from BPH. Further analysis of the data identified 210 genes with statistically significant differences in expression between prostate cancer and BPH. These genes include many not recognized previously as differentially expressed in prostate cancer and BPH, including hepsin, which codes for a transmembrane serine protease. This study reveals for the first time that significant and widespread differences in gene expression patterns exist between benign and malignant growth of the prostate gland. Gene expression analysis of prostate tissues should help to disclose the molecular mechanisms underlying prostate malignant growth and identify molecular markers for diagnostic, prognostic, and therapeutic use.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
W. Li, B.-E. Wang, P. Moran, T. Lipari, R. Ganesan, R. Corpuz, M. J.C. Ludlam, A. Gogineni, H. Koeppen, S. Bunting, et al.
Pegylated Kunitz Domain Inhibitor Suppresses Hepsin-Mediated Invasive Tumor Growth and Metastasis
Cancer Res., November 1, 2009; 69(21): 8395 - 8402.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Hu, T. A. Dunn, S. Wei, S. Isharwal, R. W. Veltri, E. Humphreys, M. Han, A. W. Partin, R. L. Vessella, W. B. Isaacs, et al.
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Cancer Res., January 1, 2009; 69(1): 16 - 22.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Tripathi, S. Nandana, H. Yamashita, R. Ganesan, D. Kirchhofer, and V. Quaranta
Laminin-332 Is a Substrate for Hepsin, a Protease Associated with Prostate Cancer Progression
J. Biol. Chem., November 7, 2008; 283(45): 30576 - 30584.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. A. Kelly, S. R. Setlur, R. Ross, R. Anbazhagan, P. Waterman, M. A. Rubin, and R. Weissleder
Detection of Early Prostate Cancer Using a Hepsin-Targeted Imaging Agent
Cancer Res., April 1, 2008; 68(7): 2286 - 2291.
[Abstract] [Full Text] [PDF]

Home page
 Brief Funct Genomic ProteomicHome page
I. G. Yulug and B. Gur-Dedeoglu
Functional genomics in translational cancer research: focus on breast cancer
Brief Funct Genomic Proteomic, March 7, 2008; (2008) eln009v1.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. A. Wallace, R. L. Prueitt, M. Yi, T. M. Howe, J. W. Gillespie, H. G. Yfantis, R. M. Stephens, N. E. Caporaso, C. A. Loffredo, and S. Ambs
Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
Cancer Res., February 1, 2008; 68(3): 927 - 936.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. S. Bjartell, H. Al-Ahmadie, A. M. Serio, J. A. Eastham, S. E. Eggener, S. W. Fine, L. Udby, W. L. Gerald, A. J. Vickers, H. Lilja, et al.
Association of Cysteine-Rich Secretory Protein 3 and {beta}-Microseminoprotein with Outcome after Radical Prostatectomy
Clin. Cancer Res., July 15, 2007; 13(14): 4130 - 4138.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Parr, A. J. Sanders, G. Davies, T. Martin, J. Lane, M. D. Mason, R. E. Mansel, and W. G. Jiang
Matriptase-2 Inhibits Breast Tumor Growth and Invasion and Correlates with Favorable Prognosis for Breast Cancer Patients
Clin. Cancer Res., June 15, 2007; 13(12): 3568 - 3576.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. S. Turley, E. C. Finger, N. Hempel, T. How, T. A. Fields, and G. C. Blobe
The Type III Transforming Growth Factor-{beta} Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer
Cancer Res., February 1, 2007; 67(3): 1090 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
B. Knudsen
Migrating with Myosin VI
Am. J. Pathol., November 1, 2006; 169(5): 1523 - 1526.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. A. Dunn, S. Chen, D. A. Faith, J. L. Hicks, E. A. Platz, Y. Chen, C. M. Ewing, J. Sauvageot, W. B. Isaacs, A. M. De Marzo, et al.
A Novel Role of Myosin VI in Human Prostate Cancer
Am. J. Pathol., November 1, 2006; 169(5): 1843 - 1854.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Moran, W. Li, B. Fan, R. Vij, C. Eigenbrot, and D. Kirchhofer
Pro-urokinase-type Plasminogen Activator Is a Substrate for Hepsin
J. Biol. Chem., October 13, 2006; 281(41): 30439 - 30446.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. C. Y. Lee, A. Frolov, R. Li, G. Ayala, and N. M. Greenberg
Targeting aurora kinases for the treatment of prostate cancer.
Cancer Res., May 15, 2006; 66(10): 4996 - 5002.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Z. Li, M. Szabolcs, J. D. Terwilliger, and A. Efstratiadis
Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene
Carcinogenesis, May 1, 2006; 27(5): 1054 - 1067.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Liu, S. Ramachandran, M. Ali Seyed, C. D. Scharer, N. Laycock, W. B. Dalton, H. Williams, S. Karanam, M. W. Datta, D. L. Jaye, et al.
Sex-determining region y box 4 is a transforming oncogene in human prostate cancer cells.
Cancer Res., April 15, 2006; 66(8): 4011 - 4019.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. K. Vanaja, K. V. Ballman, B. W. Morlan, J. C. Cheville, R. M. Neumann, M. M. Lieber, D. J. Tindall, and C. Y.F. Young
PDLIM4 Repression by Hypermethylation as a Potential Biomarker for Prostate Cancer
Clin. Cancer Res., February 15, 2006; 12(4): 1128 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
S. Nanni, C. Priolo, A. Grasselli, M. D'Eletto, R. Merola, F. Moretti, M. Gallucci, P. De Carli, S. Sentinelli, A. M. Cianciulli, et al.
Epithelial-Restricted Gene Profile of Primary Cultures from Human Prostate Tumors: A Molecular Approach to Predict Clinical Behavior of Prostate Cancer
Mol. Cancer Res., February 1, 2006; 4(2): 79 - 92.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. M. Vestergaard, M. Borre, S. S. Poulsen, E. Nexo, and N. Torring
Plasma Levels of Trefoil Factors are Increased in Patients with Advanced Prostate Cancer
Clin. Cancer Res., February 1, 2006; 12(3): 807 - 812.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. M. Berquin, Y. Min, R. Wu, H. Wu, and Y. Q. Chen
Expression Signature of the Mouse Prostate
J. Biol. Chem., October 28, 2005; 280(43): 36442 - 36451.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Talantov, A. Mazumder, J. X. Yu, T. Briggs, Y. Jiang, J. Backus, D. Atkins, and Y. Wang
Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions
Clin. Cancer Res., October 15, 2005; 11(20): 7234 - 7242.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
L. Xu, A. C. Tan, D. Q. Naiman, D. Geman, and R. L. Winslow
Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data
Bioinformatics, October 15, 2005; 21(20): 3905 - 3911.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
X. Wang, J. Yu, A. Sreekumar, S. Varambally, R. Shen, D. Giacherio, R. Mehra, J. E. Montie, K. J. Pienta, M. G. Sanda, et al.
Autoantibody Signatures in Prostate Cancer
N. Engl. J. Med., September 22, 2005; 353(12): 1224 - 1235.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Z. Gu, M. A. Rubin, Y. Yang, S. E. Deprimo, H. Zhao, S. Horvath, J. D. Brooks, M. Loda, and R. E. Reiter
Reg IV: A Promising Marker of Hormone Refractory Metastatic Prostate Cancer
Clin. Cancer Res., March 15, 2005; 11(6): 2237 - 2243.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Passioura, A. Dolnikov, S. Shen, and G. Symonds
N-Ras-Induced Growth Suppression of Myeloid Cells Is Mediated by IRF-1
Cancer Res., February 1, 2005; 65(3): 797 - 804.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y. P. Yu, S. Paranjpe, J. Nelson, S. Finkelstein, B. Ren, D. Kokkinakis, G. Michalopoulos, and J.-H. Luo
High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array
Carcinogenesis, February 1, 2005; 26(2): 471 - 479.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
A. P. Ponnampalam, G. C. Weston, A. C. Trajstman, B. Susil, and P. A.W. Rogers
Molecular classification of human endometrial cycle stages by transcriptional profiling
Mol. Hum. Reprod., December 1, 2004; 10(12): 879 - 893.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. P. Hobson, S. Netzel-Arnett, R. Szabo, S. M. Rehault, F. C. Church, D. K. Strickland, D. A. Lawrence, T. M. Antalis, and T. H. Bugge
Mouse DESC1 Is Located within a Cluster of Seven DESC1-like Genes and Encodes a Type II Transmembrane Serine Protease That Forms Serpin Inhibitory Complexes
J. Biol. Chem., November 5, 2004; 279(45): 46981 - 46994.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
M. A. Perlmutter, C. J.M. Best, J. W. Gillespie, Y. Gathright, S. Gonzalez, A. Velasco, W. M. Linehan, M. R. Emmert-Buck, and R. F. Chuaqui
Comparison of Snap Freezing versus Ethanol Fixation for Gene Expression Profiling of Tissue Specimens
J. Mol. Diagn., November 1, 2004; 6(4): 371 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. E.H. Afar, V. Bhaskar, E. Ibsen, D. Breinberg, S. M. Henshall, J. G. Kench, M. Drobnjak, R. Powers, M. Wong, F. Evangelista, et al.
Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer
Mol. Cancer Ther., August 1, 2004; 3(8): 921 - 932.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
Y. P. Yu, D. Landsittel, L. Jing, J. Nelson, B. Ren, L. Liu, C. McDonald, R. Thomas, R. Dhir, S. Finkelstein, et al.
Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of Malignancy
J. Clin. Oncol., July 15, 2004; 22(14): 2790 - 2799.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Karanam and C. S. Moreno
CONFAC: automated application of comparative genomic promoter analysis to DNA microarray datasets
Nucleic Acids Res., July 1, 2004; 32(suppl_2): W475 - W484.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A. M. Chinnaiyan
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
PNAS, June 22, 2004; 101(25): 9309 - 9314.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. Sreekumar, B. Laxman, D. R. Rhodes, S. Bhagavathula, J. Harwood, D. Giacherio, D. Ghosh, M. G. Sanda, M. A. Rubin, and A. M. Chinnaiyan
Humoral Immune Response to {alpha}-Methylacyl-CoA Racemase and Prostate Cancer
J Natl Cancer Inst, June 2, 2004; 96(11): 834 - 843.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
H. K. Lee, A. K. Hsu, J. Sajdak, J. Qin, and P. Pavlidis
Coexpression Analysis of Human Genes Across Many Microarray Data Sets
Genome Res., June 1, 2004; 14(6): 1085 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. A. Rubin, S. Varambally, R. Beroukhim, S. A. Tomlins, D. R. Rhodes, P. L. Paris, M. D. Hofer, M. Storz-Schweizer, R. Kuefer, J. A. Fletcher, et al.
Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer
Cancer Res., June 1, 2004; 64(11): 3814 - 3822.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. R. Chesire, T. A. Dunn, C. M. Ewing, J. Luo, and W. B. Isaacs
Identification of Aryl Hydrocarbon Receptor as a Putative Wnt/{beta}-Catenin Pathway Target Gene in Prostate Cancer Cells
Cancer Res., April 1, 2004; 64(7): 2523 - 2533.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Kumar-Sinha, R. B. Shah, B. Laxman, S. A. Tomlins, J. Harwood, W. Schmitz, E. Conzelmann, M. G. Sanda, J. T. Wei, M. A. Rubin, et al.
Elevated {alpha}-Methylacyl-CoA Racemase Enzymatic Activity in Prostate Cancer
Am. J. Pathol., March 1, 2004; 164(3): 787 - 793.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Lapointe, C. Li, J. P. Higgins, M. van de Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, U. Bergerheim, et al.
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
PNAS, January 20, 2004; 101(3): 811 - 816.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Zha, S. Ferdinandusse, S. Denis, R. J. Wanders, C. M. Ewing, J. Luo, A. M. De Marzo, and W. B. Isaacs
{alpha}-Methylacyl-CoA Racemase as an Androgen-Independent Growth Modifier in Prostate Cancer
Cancer Res., November 1, 2003; 63(21): 7365 - 7376.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
N. Schulke, O. A. Varlamova, G. P. Donovan, D. Ma, J. P Gardner, D. M. Morrissey, R. R. Arrigale, C. Zhan, A. J. Chodera, K. G. Surowitz, et al.
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
PNAS, October 28, 2003; 100(22): 12590 - 12595.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
G. Weston, A. C. Trajstman, C. E. Gargett, U. Manuelpillai, B. J. Vollenhoven, and P. A.W. Rogers
Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium
Mol. Hum. Reprod., September 1, 2003; 9(9): 541 - 549.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
W.A. Schulz, M. Burchardt, and M.V. Cronauer
Molecular biology of prostate cancer
Mol. Hum. Reprod., August 1, 2003; 9(8): 437 - 448.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. K. Vanaja, J. C. Cheville, S. J. Iturria, and C. Y. F. Young
Transcriptional Silencing of Zinc Finger Protein 185 Identified by Expression Profiling Is Associated with Prostate Cancer Progression
Cancer Res., July 15, 2003; 63(14): 3877 - 3882.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
D. R. Rhodes, M. G. Sanda, A. P. Otte, A. M. Chinnaiyan, and M. A. Rubin
Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate Cancer
J Natl Cancer Inst, May 7, 2003; 95(9): 661 - 668.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Khanolkar, Z. Fu, L. J. Underwood, K. L. Bondurant, R. Rochford, and M. J. Cannon
CD4+ T Cell-Induced Differentiation of EBV-Transformed Lymphoblastoid Cells Is Associated with Diminished Recognition by EBV-Specific CD8+ Cytotoxic T Cells
J. Immunol., March 15, 2003; 170(6): 3187 - 3194.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
W. Xin, D. R. Rhodes, C. Ingold, A. M. Chinnaiyan, and M. A. Rubin
Dysregulation of the Annexin Family Protein Family Is Associated with Prostate Cancer Progression
Am. J. Pathol., January 1, 2003; 162(1): 255 - 261.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Bar-Shira, J. H. Pinthus, U. Rozovsky, M. Goldstein, W. R. Sellers, Y. Yaron, Z. Eshhar, and A. Orr-Urtreger
Multiple Genes in Human 20q13 Chromosomal Region Are Involved in an Advanced Prostate Cancer Xenograft
Cancer Res., December 1, 2002; 62(23): 6803 - 6807.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Srikantan, M. Valladares, J. S. Rhim, J. W. Moul, and S. Srivastava
HEPSIN Inhibits Cell Growth/Invasion in Prostate Cancer Cells
Cancer Res., December 1, 2002; 62(23): 6812 - 6816.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. L. Zheng, B.-l. Chang, D. A. Faith, J. R. Johnson, S. D. Isaacs, G. A. Hawkins, A. Turner, K. E. Wiley, E. R. Bleecker, P. C. Walsh, et al.
Sequence Variants of {alpha}-Methylacyl-CoA Racemase Are Associated with Prostate Cancer Risk
Cancer Res., November 15, 2002; 62(22): 6485 - 6488.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Untergasser, H. B. Koch, A. Menssen, and H. Hermeking
Characterization of Epithelial Senescence by Serial Analysis of Gene Expression: Identification of Genes Potentially Involved in Prostate Cancer
Cancer Res., November 1, 2002; 62(21): 6255 - 6262.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Dash, I. P. Maine, S. Varambally, R. Shen, A. M. Chinnaiyan, and M. A. Rubin
Changes in Differential Gene Expression because of Warm Ischemia Time of Radical Prostatectomy Specimens
Am. J. Pathol., November 1, 2002; 161(5): 1743 - 1748.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Velasco, S. Cal, V. Quesada, L. M. Sanchez, and C. Lopez-Otin
Matriptase-2, a Membrane-bound Mosaic Serine Proteinase Predominantly Expressed in Human Liver and Showing Degrading Activity against Extracellular Matrix Proteins
J. Biol. Chem., September 27, 2002; 277(40): 37637 - 37646.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Kuefer, S. Varambally, M. Zhou, P. C. Lucas, M. Loeffler, H. Wolter, T. Mattfeldt, R. E. Hautmann, J. E. Gschwend, T. R. Barrette, et al.
{alpha}-Methylacyl-CoA Racemase: Expression Levels of this Novel Cancer Biomarker Depend on Tumor Differentiation
Am. J. Pathol., September 1, 2002; 161(3): 841 - 848.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. R. Rhodes, T. R. Barrette, M. A. Rubin, D. Ghosh, and A. M. Chinnaiyan
Meta-Analysis of Microarrays: Interstudy Validation of Gene Expression Profiles Reveals Pathway Dysregulation in Prostate Cancer
Cancer Res., August 1, 2002; 62(15): 4427 - 4433.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. LaTulippe, J. Satagopan, A. Smith, H. Scher, P. Scardino, V. Reuter, and W. L. Gerald
Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated with Metastatic Disease
Cancer Res., August 1, 2002; 62(15): 4499 - 4506.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. F. Macgregor and J. A. Squire
Application of Microarrays to the Analysis of Gene Expression in Cancer
Clin. Chem., August 1, 2002; 48(8): 1170 - 1177.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
T.-K. Jenssen, M. Langaas, W. P. Kuo, B. Smith-Sorensen, O. Myklebost, and E. Hovig
Analysis of repeatability in spotted cDNA microarrays
Nucleic Acids Res., July 15, 2002; 30(14): 3235 - 3244.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Iizuka, M. Oka, H. Yamada-Okabe, N. Mori, T. Tamesa, T. Okada, N. Takemoto, A. Tangoku, K. Hamada, H. Nakayama, et al.
Comparison of Gene Expression Profiles between Hepatitis B Virus- and Hepatitis C Virus-infected Hepatocellular Carcinoma by Oligonucleotide Microarray Data on the Basis of a Supervised Learning Method
Cancer Res., July 15, 2002; 62(14): 3939 - 3944.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. Karan, D. L. Kelly, A. Rizzino, M.-F. Lin, and S. K. Batra
Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells
Carcinogenesis, June 1, 2002; 23(6): 967 - 976.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Ernst, M. Hergenhahn, M. Kenzelmann, C. D. Cohen, M. Bonrouhi, A. Weninger, R. Klaren, E. F. Grone, M. Wiesel, C. Gudemann, et al.
Decrease and Gain of Gene Expression Are Equally Discriminatory Markers for Prostate Carcinoma : A Gene Expression Analysis on Total and Microdissected Prostate Tissue
Am. J. Pathol., June 1, 2002; 160(6): 2169 - 2180.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
F. Francioso, F. Carinci, L. Tosi, L. Scapoli, F. Pezzetti, E. Passerella, R. Evangelisti, A. Pastore, S. Pelucchi, A. Piattelli, et al.
Identification of Differentially Expressed Genes in Human Salivary Gland Tumors by DNA Microarrays
Mol. Cancer Ther., May 1, 2002; 1(7): 533 - 538.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. A. Rubin, M. Zhou, S. M. Dhanasekaran, S. Varambally, T. R. Barrette, M. G. Sanda, K. J. Pienta, D. Ghosh, and A. M. Chinnaiyan
{alpha}-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer
JAMA, April 3, 2002; 287(13): 1662 - 1670.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Luo, S. Zha, W. R. Gage, T. A. Dunn, J. L. Hicks, C. J. Bennett, C. M. Ewing, E. A. Platz, S. Ferdinandusse, R. J. Wanders, et al.
{alpha}-Methylacyl-CoA Racemase: A New Molecular Marker for Prostate Cancer
Cancer Res., April 1, 2002; 62(8): 2220 - 2226.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Shou, R. Soriano, S. W. Hayward, G. R. Cunha, P. M. Williams, and W.-Q. Gao
Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression
PNAS, March 5, 2002; 99(5): 2830 - 2835.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
J. A. Macoska
The Progressing Clinical Utility of DNA Microarrays
CA Cancer J Clin, January 1, 2002; 52(1): 50 - 59.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. L. Strausberg and G. J. Riggins
Navigating the human transcriptome
PNAS, October 9, 2001; 98(21): 11837 - 11838.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
J. B. Welsh, L. M. Sapinoso, A. I. Su, S. G. Kern, J. Wang-Rodriguez, C. A. Moskaluk, H. F. Frierson Jr., and G. M. Hampton
Analysis of Gene Expression Identifies Candidate Markers and Pharmacological Targets in Prostate Cancer
Cancer Res., August 1, 2001; 61(16): 5974 - 5978.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.